Work

A Phase 1/2 Multicenter Randomized Trial of Local Ablation plus Toripalimab versus Toripalimab Alone for Previously Treated Unresectable Hepatocellular Carcinoma

Year: 2023

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-23-0410

Authors: Chunhui Zhou, Yan Li, Jiaping Li, Botian Song, Hanfeng Li, Bin Liang, Shanzhi Gu, Haiping Li, Changyong Chen, Sai Li, Changli Peng, Fei Liu, Juxiong Xiao, Xueying Long, Ping Li, Zhengping Xiong, Xiaoping Yi, Weihua Liao, Liangrong Shi

Institutions: Central South University, Xiangya Hospital Central South University, Hunan University of Traditional Chinese Medicine, First Affiliated Hospital of Hunan University of Traditional Chinese Medicine, Sun Yat-sen University, The First Affiliated Hospital, Sun Yat-sen University, Huazhong University of Science and Technology, Hunan Cancer Hospital

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Health Commission of Hunan Province, Shanghai Junshi Biosciences, National Natural Science Foundation of China

Awards: G4090141215, G539625072

OpenAlex ID: W4377939161

FWCI: 3.023

Cites: 36

Cited by: 25

Related to: 10